{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:56:41Z","timestamp":1773403001199,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13149-x","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T09:51:42Z","timestamp":1731318702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic value of FDX1, the cuprotosis key gene, and its prediction models across imaging modalities and histology"],"prefix":"10.1186","volume":"24","author":[{"given":"Qiuyuan","family":"Yue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsheng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"13149_CR1","doi-asserted-by":"crossref","unstructured":"1. Siegel RL, Miller KD, Wagle NS, Jemal A: Cancer statistics, 2023. CA Cancer J Clin 2023, 73(1):17\u201348.","DOI":"10.3322\/caac.21763"},{"key":"13149_CR2","doi-asserted-by":"crossref","unstructured":"2. Sun Q, Chen Y, Liang C, Zhao Y, Lv X, Zou Y, Yan K, Zheng H, Liang D, Li Z-C: Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma. Radiology 2021, 301(3):654\u2013663.","DOI":"10.1148\/radiol.2021203281"},{"key":"13149_CR3","doi-asserted-by":"crossref","unstructured":"3. Yan J, Liu L, Wang W, Zhao Y, Li KK-W, Li K, Wang L, Yuan B, Geng H, Zhang S et al: Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With Medulloblastoma. Front Oncol 2020, 10:558162.","DOI":"10.3389\/fonc.2020.558162"},{"key":"13149_CR4","doi-asserted-by":"crossref","unstructured":"4. van Geel JJL, Boers J, Elias SG, Glaudemans AWJM, de Vries EFJ, Hospers GAP, van Kruchten M, Kuip EJM, Jager A, Menke-van der Houven van Oordt WC et al: Clinical Validity of 16\u03b1-[F]Fluoro-17\u03b2-Estradiol Positron Emission Tomography\/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer. J Clin Oncol 2022:JCO2200400.","DOI":"10.1200\/JCO.22.00400"},{"key":"13149_CR5","doi-asserted-by":"crossref","unstructured":"5. Choi YS, Ahn SS, Chang JH, Kang S-G, Kim EH, Kim SH, Jain R, Lee S-K: Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction. Eur Radiol 2020, 30(7):3834\u20133842.","DOI":"10.1007\/s00330-020-06737-5"},{"key":"13149_CR6","doi-asserted-by":"crossref","unstructured":"6. Duan J, Zhao Y, Sun Q, Liang D, Liu Z, Chen X, Li Z-C: Imaging-proteomic analysis for prediction of neoadjuvant chemotherapy responses in patients with breast cancer. Cancer Med 2023, 12(23):21256\u201321269.","DOI":"10.1002\/cam4.6704"},{"key":"13149_CR7","doi-asserted-by":"crossref","unstructured":"7. Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD et al: Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 2022, 375(6586):1254\u20131261.","DOI":"10.1126\/science.abf0529"},{"key":"13149_CR8","doi-asserted-by":"crossref","unstructured":"8. Yan C, Han Z, Chen X, Gao L, Ye R, Li Y: Diffusion-Weighted Imaging as a Quantitative Imaging Biomarker for Predicting Proliferation Rate in Hepatocellular Carcinoma: Developing a Radiomics Nomogram. J Comput Assist Tomogr 2023, 47(4):539\u2013547.","DOI":"10.1097\/RCT.0000000000001448"},{"key":"13149_CR9","doi-asserted-by":"crossref","unstructured":"9. Hong F, Meng Q, Zhang W, Zheng R, Li X, Cheng T, Hu D, Gao X: Single-Cell Analysis of the Pan-Cancer Immune Microenvironment and scTIME Portal. Cancer Immunol Res 2021, 9(8):939\u2013951.","DOI":"10.1158\/2326-6066.CIR-20-1026"},{"key":"13149_CR10","doi-asserted-by":"crossref","unstructured":"10. Hu JF, Song X, Zhong K, Zhao XK, Zhou FY, Xu RH, Li JL, Wang XZ, Li XM, Wang PP et al: Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma. Front Oncol 2023, 13:997776.","DOI":"10.3389\/fonc.2023.997776"},{"key":"13149_CR11","doi-asserted-by":"crossref","unstructured":"11. Dogan S, Vasudevaraja V, Xu B, Serrano J, Ptashkin RN, Jung HJ, Chiang S, Jungbluth AA, Cohen MA, Ganly I et al: DNA methylation-based classification of sinonasal undifferentiated carcinoma. Mod Pathol 2019, 32(10):1447\u20131459.","DOI":"10.1038\/s41379-019-0285-x"},{"key":"13149_CR12","doi-asserted-by":"crossref","unstructured":"12. Hanahan D: Hallmarks of Cancer: New Dimensions. Cancer Discov 2022, 12(1):31\u201346.","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"13149_CR13","doi-asserted-by":"crossref","unstructured":"13. Khouja HI, Ashankyty IM, Bajrai LH, Kumar PKP, Kamal MA, Firoz A, Mobashir M: Multi-staged gene expression profiling reveals potential genes and the critical pathways in kidney cancer. Sci Rep 2022, 12(1):7240.","DOI":"10.1038\/s41598-022-11143-6"},{"key":"13149_CR14","doi-asserted-by":"crossref","unstructured":"14. Zhang J, Kong X, Zhang Y, Sun W, Wang J, Chen M, Chen X: FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression. J Pathol 2020, 251(3):284\u2013296.","DOI":"10.1002\/path.5451"},{"key":"13149_CR15","doi-asserted-by":"crossref","unstructured":"15. Garc\u00eda-Heredia JM, Carnero A: Role of Mitochondria in Cancer Stem Cell Resistance. Cells 2020, 9(7).","DOI":"10.3390\/cells9071693"},{"key":"13149_CR16","doi-asserted-by":"crossref","unstructured":"16. Hsu C-C, Tseng L-M, Lee H-C: Role of mitochondrial dysfunction in cancer progression. Exp Biol Med (Maywood) 2016, 241(12):1281\u20131295.","DOI":"10.1177\/1535370216641787"},{"key":"13149_CR17","doi-asserted-by":"crossref","unstructured":"17. Ping Y, Shan J, Qin H, Li F, Qu J, Guo R, Han D, Jing W, Liu Y, Liu J et al: PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8\u2009+\u2009T cell ferroptosis. Immunity 2024, 57(9).","DOI":"10.1016\/j.immuni.2024.08.003"},{"key":"13149_CR18","doi-asserted-by":"crossref","unstructured":"18. Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue RTHM, Even AJG, Jochems A et al: Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 2017, 14(12):749\u2013762.","DOI":"10.1038\/nrclinonc.2017.141"},{"key":"13149_CR19","doi-asserted-by":"crossref","unstructured":"19. Yan J, Zhao Y, Chen Y, Wang W, Duan W, Wang L, Zhang S, Ding T, Liu L, Sun Q et al: Deep learning features from diffusion tensor imaging improve glioma stratification and identify risk groups with distinct molecular pathway activities. EBioMedicine 2021, 72:103583.","DOI":"10.1016\/j.ebiom.2021.103583"},{"key":"13149_CR20","doi-asserted-by":"crossref","unstructured":"20. Zhao Y, Liu G, Sun Q, Zhai G, Wu G, Li Z-C: Validation of CT radiomics for prediction of distant metastasis after surgical resection in patients with clear cell renal cell carcinoma: exploring the underlying signaling pathways. Eur Radiol 2021, 31(7):5032\u20135040.","DOI":"10.1007\/s00330-020-07590-2"},{"key":"13149_CR21","doi-asserted-by":"crossref","unstructured":"21. Yan J, Sun Q, Tan X, Liang C, Bai H, Duan W, Mu T, Guo Y, Qiu Y, Wang W et al: Image-based deep learning identifies glioblastoma risk groups with genomic and transcriptomic heterogeneity: a multi-center study. Eur Radiol 2023, 33(2):904\u2013914.","DOI":"10.1007\/s00330-022-09066-x"},{"key":"13149_CR22","doi-asserted-by":"crossref","unstructured":"22. Rossi G, Barabino E, Fedeli A, Ficarra G, Coco S, Russo A, Adamo V, Buemi F, Zullo L, Dono M et al: Radiomic Detection of EGFR Mutations in NSCLC. Cancer Res 2021, 81(3):724\u2013731.","DOI":"10.1158\/0008-5472.CAN-20-0999"},{"key":"13149_CR23","doi-asserted-by":"crossref","unstructured":"23. Bi S, Li J, Wang T, Man F, Zhang P, Hou F, Wang H, Hao D: Multi-parametric MRI-based radiomics signature for preoperative prediction of Ki-67 proliferation status in sinonasal malignancies: a two-centre study. Eur Radiol 2022.","DOI":"10.1007\/s00330-022-08780-w"},{"key":"13149_CR24","doi-asserted-by":"crossref","unstructured":"24. Zhang Q-W, Gao Y-J, Zhang R-Y, Zhou X-X, Chen S-L, Zhang Y, Liu Q, Xu J-R, Ge Z-Z: Personalized CT-based radiomics nomogram preoperative predicting Ki-67 expression in gastrointestinal stromal tumors: a multicenter development and validation cohort. Clin Transl Med 2020, 9(1):12.","DOI":"10.1186\/s40169-020-0263-4"},{"key":"13149_CR25","doi-asserted-by":"crossref","unstructured":"25. Li Z-Y, Wang X-D, Li M, Liu X-J, Ye Z, Song B, Yuan F, Yuan Y, Xia C-C, Zhang X et al: Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer. World J Gastroenterol 2020, 26(19):2388\u20132402.","DOI":"10.3748\/wjg.v26.i19.2388"},{"key":"13149_CR26","doi-asserted-by":"crossref","unstructured":"26. Pai S, Bontempi D, Prudente V, Hadzic I, Soka\u010d M, Chaunzwa TL, Bernatz S, Hosny A, Mak RH, Birkbak NJ et al: Foundation Models for Quantitative Biomarker Discovery in Cancer Imaging. medRxiv 2023.","DOI":"10.1101\/2023.09.04.23294952"},{"key":"13149_CR27","doi-asserted-by":"crossref","unstructured":"27. Wu J, Li C, Gensheimer M, Padda S, Kato F, Shirato H, Wei Y, Sch\u00f6nlieb C-B, Price SJ, Jaffray D et al: Radiological tumor classification across imaging modality and histology. Nat Mach Intell 2021, 3:787\u2013798.","DOI":"10.1038\/s42256-021-00377-0"},{"key":"13149_CR28","doi-asserted-by":"crossref","unstructured":"28. Braman N, Prasanna P, Whitney J, Singh S, Beig N, Etesami M, Bates DDB, Gallagher K, Bloch BN, Vulchi M et al: Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer. JAMA Netw Open 2019, 2(4):e192561.","DOI":"10.1001\/jamanetworkopen.2019.2561"},{"key":"13149_CR29","doi-asserted-by":"crossref","unstructured":"29. Li Z-C, Bai H, Sun Q, Zhao Y, Lv Y, Zhou J, Liang C, Chen Y, Liang D, Zheng H: Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma. Cancer Med 2018, 7(12):5999\u20136009.","DOI":"10.1002\/cam4.1863"},{"key":"13149_CR30","doi-asserted-by":"crossref","unstructured":"30. Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, Verlingue L, Brandao D, Lancia A, Ammari S et al: A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol 2018, 19(9):1180\u20131191.","DOI":"10.1016\/S1470-2045(18)30413-3"},{"key":"13149_CR31","doi-asserted-by":"crossref","unstructured":"31. Li H, Zhu Y, Burnside ES, Drukker K, Hoadley KA, Fan C, Conzen SD, Whitman GJ, Sutton EJ, Net JM et al: MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays. Radiology 2016, 281(2):382\u2013391.","DOI":"10.1148\/radiol.2016152110"},{"key":"13149_CR32","doi-asserted-by":"crossref","unstructured":"32. Bao H, Chen T, Zhu J, Xie H, Chen F: CEUS-Based Radiomics Can Show Changes in Protein Levels in Liver Metastases After Incomplete Thermal Ablation. Front Oncol 2021, 11:694102.","DOI":"10.3389\/fonc.2021.694102"},{"key":"13149_CR33","doi-asserted-by":"crossref","unstructured":"33. Grossmann P, Gutman DA, Dunn WD, Holder CA, Aerts HJWL: Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma. BMC Cancer 2016, 16:611.","DOI":"10.1186\/s12885-016-2659-5"},{"key":"13149_CR34","doi-asserted-by":"crossref","unstructured":"34. Katsoulakis E, Yu Y, Apte AP, Leeman JE, Katabi N, Morris L, Deasy JO, Chan TA, Lee NY, Riaz N et al: Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma. Oral Oncol 2020, 110:104877.","DOI":"10.1016\/j.oraloncology.2020.104877"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13149-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13149-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13149-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T10:08:44Z","timestamp":1731319724000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13149-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["13149"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13149-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"10 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. It\u2019s approved by the Hospital Ethics Association (Ethics number: [2021] No. 090, the First Affiliated Hospital of Fujian Medical University). Patient anonymity was preserved, and informed consent was exempted in this retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1381"}}